AstraZeneca
The companies will also be looking into using Eko's tech in clinical trials.
The digital respiratory health company says this deal and clearance now give it access to 90% of the U.S. asthma and COPD market.
Also: Providence supporting COVID-19 patients at home with Xealth and Twistle; Lief Therapeutics incorporates DrChrono's Open API.
The initiative is based on a strategic partnership between the company and Jerusalem Venture Partners, Microsoft, Israeli entrepreneur Morris Kahn and others.
Funds will be used to acquire more data sets and develop AI analysis.